DE69719382T2 - VERFAHREN ZUR HERSTELLUNG VON rDSPA Alpha1 - Google Patents

VERFAHREN ZUR HERSTELLUNG VON rDSPA Alpha1

Info

Publication number
DE69719382T2
DE69719382T2 DE69719382T DE69719382T DE69719382T2 DE 69719382 T2 DE69719382 T2 DE 69719382T2 DE 69719382 T DE69719382 T DE 69719382T DE 69719382 T DE69719382 T DE 69719382T DE 69719382 T2 DE69719382 T2 DE 69719382T2
Authority
DE
Germany
Prior art keywords
rdspa
alpha1
producing
chromatography
ending
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69719382T
Other languages
English (en)
Other versions
DE69719382D1 (de
Inventor
Michael Mccaman
Erno Pungor
Carol Souders
P Tan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of DE69719382D1 publication Critical patent/DE69719382D1/de
Publication of DE69719382T2 publication Critical patent/DE69719382T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Paper (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69719382T 1996-02-05 1997-01-31 VERFAHREN ZUR HERSTELLUNG VON rDSPA Alpha1 Expired - Lifetime DE69719382T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/597,059 US5731186A (en) 1996-02-05 1996-02-05 Method for the production of rDSPA α1
PCT/EP1997/000441 WO1997029188A1 (en) 1996-02-05 1997-01-31 METHOD FOR THE PRODUCTION OF rDSPA α1

Publications (2)

Publication Number Publication Date
DE69719382D1 DE69719382D1 (de) 2003-04-03
DE69719382T2 true DE69719382T2 (de) 2003-11-27

Family

ID=24389906

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69719382T Expired - Lifetime DE69719382T2 (de) 1996-02-05 1997-01-31 VERFAHREN ZUR HERSTELLUNG VON rDSPA Alpha1

Country Status (23)

Country Link
US (1) US5731186A (de)
EP (1) EP1015568B1 (de)
JP (1) JP3805378B2 (de)
KR (1) KR100508043B1 (de)
CN (1) CN1242059C (de)
AT (1) ATE233316T1 (de)
AU (1) AU706286B2 (de)
CZ (1) CZ294827B6 (de)
DE (1) DE69719382T2 (de)
DK (1) DK1015568T3 (de)
ES (1) ES2193349T3 (de)
HK (1) HK1018795A1 (de)
HU (1) HU223902B1 (de)
IL (1) IL124952A (de)
NO (1) NO322527B1 (de)
PL (1) PL186410B1 (de)
PT (1) PT1015568E (de)
RU (1) RU2223315C2 (de)
SK (1) SK284179B6 (de)
TW (1) TW385313B (de)
UA (1) UA62925C2 (de)
WO (1) WO1997029188A1 (de)
ZA (1) ZA97948B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100436655B1 (ko) * 2001-07-25 2004-06-22 (주)엘피스바이오텍 광범위한 단백질에 적용할 수 있는 단백질의 농축 및정제 방법
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
DE202006015207U1 (de) * 2006-05-19 2007-08-16 Paion Deutschland Gmbh Verwendung vn Plasminogenaktivatoren zur Behandlung einer Venenthromboembolie
AR068914A1 (es) * 2007-10-18 2009-12-16 Paion Deutschland Gmbh Uso de un activador de plasminogeno para la preparacion de un medicamento para el tratamiento de apoplejia
EP2558580A2 (de) * 2010-04-16 2013-02-20 H. Lundbeck A/S Verfahren zur herstellung von rekombinantem dspa-alpha1
US20120258519A1 (en) * 2011-04-10 2012-10-11 Therapeutic Proteins Inc. Protein Harvesting
EP3302784B1 (de) 2015-06-05 2021-10-06 W.R. Grace & Co.-Conn. Adsorbierende klärmittel für bioprozesstechnik und verfahren zur herstellung und verwendung davon

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3512910A1 (de) * 1985-04-11 1986-10-16 Behringwerke Ag, 3550 Marburg Verfahren zur reinigung von plasminogenaktivatoren
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
US4898825A (en) * 1986-05-07 1990-02-06 Mitsui Toatsu Chemicals, Incorporated Methods for purification of single-chain and double-chain tissue plasminogen activator
JPS6463378A (en) * 1986-08-11 1989-03-09 Mitsui Toatsu Chemicals Separation of single stranded tpa and double standard tpa
US4929560A (en) * 1988-02-03 1990-05-29 Damon Biotech, Inc. Recovery of tissue plasminogen activator
IE69054B1 (en) * 1988-07-20 1996-08-07 Schering Ag Vampire bat salivary plasminogen activators
UA34415C2 (uk) * 1989-02-13 2001-03-15 Шерінг Аг Берлін Унд Бергкамен Істотно чистий білок, що є тромболітиком, виділена днк, що його кодує, культура яйцеклітин xenopus laevis, трансформованих вектором, спосіб одержання активатора плазміногена, лікарський тромболітичний засіб
DE3943241A1 (de) * 1989-12-22 1991-06-27 Schering Ag Thrombolytisch wirkendes kombinationspraeparat
US5141862A (en) * 1990-04-17 1992-08-25 Smithkline Beecham Corporation Method of purifying tpa or plasminogen activator using a tripeptide of the formula: -X-Y-argininal wherein X and Y are selected from the group consisting of pro,phe,trp and tyr

Also Published As

Publication number Publication date
TW385313B (en) 2000-03-21
ZA97948B (en) 1997-08-19
DK1015568T3 (da) 2003-06-10
PT1015568E (pt) 2003-07-31
UA62925C2 (en) 2004-01-15
JP2000504565A (ja) 2000-04-18
KR19990082306A (ko) 1999-11-25
HK1018795A1 (en) 2000-01-07
ATE233316T1 (de) 2003-03-15
IL124952A (en) 2002-08-14
PL328146A1 (en) 1999-01-18
JP3805378B2 (ja) 2006-08-02
CN1242059C (zh) 2006-02-15
CN1210559A (zh) 1999-03-10
HUP9901029A2 (hu) 1999-07-28
NO983579D0 (no) 1998-08-04
AU706286B2 (en) 1999-06-10
CZ294827B6 (cs) 2005-03-16
RU2223315C2 (ru) 2004-02-10
CZ245598A3 (cs) 1999-01-13
AU1546297A (en) 1997-08-28
US5731186A (en) 1998-03-24
WO1997029188A1 (en) 1997-08-14
SK284179B6 (sk) 2004-10-05
EP1015568B1 (de) 2003-02-26
NO983579L (no) 1998-10-05
HU223902B1 (hu) 2005-03-29
SK103298A3 (en) 1999-03-12
PL186410B1 (pl) 2004-01-30
HUP9901029A3 (en) 2001-10-29
KR100508043B1 (ko) 2005-12-21
NO322527B1 (no) 2006-10-16
ES2193349T3 (es) 2003-11-01
IL124952A0 (en) 1999-01-26
EP1015568A1 (de) 2000-07-05
DE69719382D1 (de) 2003-04-03

Similar Documents

Publication Publication Date Title
EP1193271A3 (de) Zusammensetzungen und Methoden zur strukturellen Proteinbestimmung
DE69716767T2 (de) Verfahren zur herstellung von tolterodin
EP0670370A3 (de) Verfahren zur Herstellung von Glutaminsäure durch Fermentation.
ID17698A (id) Proses untuk memproduksi asam l-glutamat dengan fermentasi
DE58903791D1 (de) Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung.
DE69405683D1 (de) Verfahren zur Herstellung von cis-1,4-Polybutadien mit verminderter Gelbildung
DE69007800D1 (de) Verfahren zur fermentativen Herstellung von L-Arginin.
DE69629299D1 (de) Prozess für die produktion von l-lysin durch fermentation
DE69719382D1 (de) VERFAHREN ZUR HERSTELLUNG VON rDSPA Alpha1
PH31685A (en) Method of producing l-glutamic acid by fermentation.
DE3587118D1 (de) Verfahren zur herstellung eines verbundglases.
ATE397088T1 (de) Verfahren zur herstellung von (s)- oder (r)-3,3,3-trifluor-2-hydroxy-2-methylpropionsaü e
DE69100706T2 (de) Kohlenstoffperlen, Verfahren zur Herstellung und Chromatographiesäule, die sie enthält.
DE3673054D1 (de) Kontinuierliches verfahren zur herstellung von ethanol durch bakterielle fermentation.
DE58905010D1 (de) Verfahren zur herstellung von 5-chlor-3-chlorsulfonyl-2-thiophencarbonsaeureestern.
DE3580156D1 (de) Verfahren zur herstellung eines mit kaltluftkanaelen versehenen kuehlschrankes.
CA2245554A1 (en) Method for the production of rdspa .alpha.1
DE59000677D1 (de) Verfahren zur herstellung von 2-cyan-3,3-diarylacrylsaeureestern.
DE69526992T2 (de) Fermentationsprozess für die Herstellung von Phenylessigsäure mit Phenylalanin als Ausgangskomponente
DE69803769T2 (de) Verfahren zur herstellung von 3,3-dimethylbutyraldehyd
DE68902007T2 (de) Verfahren zur herstellung von trans-2,2-dimethyl-3-(2,2-dihalovinyl)-cyclopropancarbonsaeurehalogeniden.
ATE123495T1 (de) Verfahren zur herstellung 2-chlor-1,7- dihydropurin-6-on und verfahren zu dessen reinigung.
DE68904244T2 (de) Verfahren zur herstellung von trans-2,2-dimethyl-3-(2,2-dihalovinyl)-cyclopropancarbonsaeureestern.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AG, 13353 BERLIN, DE

8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AKIENGESELLSCHAFT, 13353, DE